Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|May 22, 2014
Population pharmacokinetics of brodalumab in healthy adults and adults with psoriasis from single and multiple dose studiesChristopher J Endres, David H Salinger, Kathleen Köck, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
An Exposure-Response Perspective on the Clinical Dose of PretomanidJerry R Nedelman, David H Salinger, Vishak Subramoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Real-time dose adjustment of cyclophosphamide in a preparative regimen for hematopoietic cell transplant: a Bayesian pharmacokinetic approachDavid H Salinger, Jeannine S McCune, Aaron G Ren, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2009
Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administrationMeng Li, Marilee A Andrew, Joanne Wang, et al.
Clinical Pharmacokinetics|January 19, 2011
Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human predictionJennifer Q Dong, David H Salinger, Christopher J Endres, et al.
Anesthesia and Analgesia|April 26, 2007
Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokineticsAnne M Lynn, Heidi Bradford, Eric D Kantor, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 2, 2024
Recommendation of mavacamten posology by model-based analyses in adults with obstructive hypertrophic cardiomyopathySamira Merali, David H Salinger, Maria Palmisano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2014
Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibodyChris B Russell, Hugh Rand, Jeannette Bigler, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titrationPeter Chang, Vidya Perera, David H Salinger, et al.
Pharmacology Research & Perspectives|February 19, 2015
Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseasesHong Li, Kathleen Köck, John A Wisler, et al.
Pageof 3